Using population data to examine the prevalence and correlates of neonatal abstinence syndrome

Drug and Alcohol Review

Volumn 26, Issue 5, 2007, Pages 487-492

  Burns, Lucy ^a   Mattick, Richard P ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Linked data; Methadone; Neonatal abstinence syndrome; Pregnancy

Indexed keywords

METHADONE; NARCOTIC AGENT;

ABORIGINE; ADULT; ARTICLE; AUSTRALIA; CROSS-SECTIONAL STUDY; ETHNOLOGY; FACTUAL DATABASE; FEMALE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MEDICAL RECORD; NEWBORN; NEWBORN INTENSIVE CARE; OPIATE ADDICTION; PREGNANCY; PREGNANCY COMPLICATION; PREVALENCE; RISK FACTOR; SMOKING; STATISTICS; WITHDRAWAL SYNDROME;

ADULT; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; FEMALE; GRAVIDITY; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; INTERNATIONAL CLASSIFICATION OF DISEASES; MEDICAL RECORD LINKAGE; METHADONE; NARCOTICS; NEONATAL ABSTINENCE SYNDROME; NEW SOUTH WALES; OCEANIC ANCESTRY GROUP; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE; RISK FACTORS; SMOKING;

EID: 34547947082     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1080/09595230701494416     Document Type: Article

References (27)

1. Kandall SR, Albin S, Gartner LM, Lee KS, Eidelman A, Lowinson J. The narcotic-dependent mother: fetal and neonatal consequences. Early Hum Dev 1977;1:159-69.
2. Gutierres SE, Barr A. The relationship between attitudes toward pregnancy and contraception use among drug users. J Subst Abuse Treat 2003;24:19-29.
3. Fischer G. Treatment of opioid dependence in pregnant women [see comment]. Addiction 2000;95:1141-4.
4. Crandall C, Crosby RD, Carlson GA. Does pregnancy affect outcome of methadone maintenance treatment? J Subst Abuse Treat 2004;26:4:295-303.
5. Kandall SR, Doberczak TM, Jantunen M, Stein J. The methadone-maintained pregnancy. Clin Perinatol 1999;26:173-83.
6. Greene CM, Goodman MH. Neonatal abstinence syndrome: strategies for care of the drug-exposed infant. Neonat Netw J Neonat Nurs 2003;22:15-25.
7. Finnegan LP. Treatment issues for opioid-dependent women during the perinatal period. J Psychoact Drugs 1991;23:191-201.
8. Finnegan LP, Kendall SR. Neonatal abstinence syndromes. In: Arando J, Jaffe SJ, eds. Neonatal and pediatric pharmacology: therapeutic principles in practice. Philadelphia, PA: Lippincott, Williams and Wilkins, 2005:848-57.
9. Johnson K, Gerada C, Greenough A. Treatment of neonatal abstinence syndrome. Arch Dis Child Fetal Neonat Edn 2003;88:F2-5.
10. van Baar AL, Fleury P, Soepatmi S, Ultee CA, Wesselman PJ. Neonatal behavior after drug dependent pregnancy. Arch Dis Child 1989;64:235-40.
11. Johnson K, Greenough A, Gerada C. Maternal drug use and length of neonatal unit stay. Addiction 2003;98:785-9.
12. Coghlan D, Milner M, Clarke T, et al. Neonatal abstinence syndrome. Irish Med J 1999;179:232-3.
13. Zellman GL, Jacobson PD, DuPlessis H, DiMatteo MR. Detecting prenatal substance exposure: an exploratory analysis and policy discussion. J Drug Issues 1993;23:375-87.
14. Jones HC. Shorter dosing interval of opiate solution shortens hospital stay for methadone babies. Fam Med 1999;31:327-30.
15. Lee TS. Slow-release morphine was not more effective than methadone in reducing neonatal abstinence syndrome. Western J Med 2000;172:26.
16. Schindler SD, Eder H, Ortner R, Rohrmeister K, Langer M, Fischer G. Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Addiction 2003;98:103-10.
17. Sinha C, Ohadike P, Carrick P, Pairaudeau P, Armstrong D, Lindow SW. Neonatal outcome following maternal opiate use in late pregnancy. Int J Gynaecol Obstet 2001;74:241-6.
18. Berghella V, Lim PJ, Hill MK, Cherpes J, Chennat J, Kaltenbach K. Maternal methadone dose and neonatal withdrawal [see comment], Am J Obstet Gynecol 2003;189:312-17.
19. Holman CD, Bass AJ, Rouse IL, Hobbs MS. Population-based linkage of health records in Western Australia: development of a health services research linked database [see comment]. Aust NZ J Public Health 1999;23:453-9.
20. Hall W, Ross J, Lynskey M, Law M, Degenhardt L. How many dependent opioid users are there in Australia? Med J Aust 2000;173:528-31.
21. National Centre for Classification in Health. The international statistical classification of diseases and related health problems, 10th revision, Australian modification (ICD-10-AM). Sydney: National Centre for Classification in Health, Faculty of Science, Sydney University, 1998.
22. Hall W, Ross J, Lynskey M, Law M, Degenhardt L. How many dependent heroin users are there in Australia? Sydney: National Drug and Alcohol Research Centre, 2000.
23. Kelly JJ, Davis PG, Henschke PN. The drug epidemic: effects on newborn infants and health resource consumption at a tertiary perinatal centre. J Paediatr Child Health 2000;36:262-4.
24. Shaw NJ, McIvor L. Neonatal abstinence syndrome after maternal methadone treatment [see comment]. Arch Dis Child Fetal Neonat Edn 1994;71:F203-5.
25. Choo RE, Huestis MA, Schroeder JR, Shin AS, Jones HE. Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure. Drug Alcohol Depend 2004;75:253-60.
26. Roberts C, Tracy S, Peat B. Rates of obstetric intervention among private and public patients in Australia: population based descriptive study. BMJ 2005;321:137-41.
27. Churches T, Lim K. Using record linkage to measure trends in breast cancer surgery. NSW Public Health Bull 2001;12:105-10.